Establishment Labs Holdings Inc. ESTA

ESTA Company Overview

Establishment Labs Holdings Inc. is a Costa Rica–based medical technology company focused on aesthetic and reconstructive plastic surgery products, primarily breast implants and related surgical technologies. The company operates within the global medical aesthetics and medical device industries and is best known for its proprietary Motiva line of silicone breast implants, which are marketed for both cosmetic augmentation and post-mastectomy reconstruction procedures. Its revenue is primarily generated through sales of implant products, complementary surgical tools, and associated aesthetic technologies distributed through plastic surgeons, hospitals, and specialty clinics.

The company was founded in 2004 by Juan José Chacón-Quirós and evolved from a regional implant manufacturer into a globally distributed medical aesthetics platform. Establishment Labs has positioned itself around premium implant technology, safety-focused product design, and minimally invasive surgical approaches. The company’s strategic differentiation has centered on proprietary implant surface technologies, ergonomic implant designs, and digital surgery integration initiatives. Public filings and industry reporting indicate that the company has expanded significantly outside the United States, particularly across Europe, Latin America, and parts of Asia-Pacific, while continuing efforts to increase penetration in the U.S. market following regulatory approvals.